rs864321624
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_178526.5(SLC25A42):c.871A>G(p.Asn291Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_178526.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A42 | NM_178526.5 | c.871A>G | p.Asn291Asp | missense_variant | Exon 8 of 8 | ENST00000318596.8 | NP_848621.2 | |
SLC25A42 | NM_001321544.2 | c.871A>G | p.Asn291Asp | missense_variant | Exon 8 of 8 | NP_001308473.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression Pathogenic:9
- -
- -
- -
This variant is interpreted as a Pathogenic for Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, autosomal recessive. The following ACMG Tag(s) were applied: PM2, PP3, PM3, PS3, PP1-Strong. -
- -
- -
- -
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
- -
SLC25A42-related mitochondrial disorder Pathogenic:1
- -
Inborn mitochondrial myopathy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at